These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Clinical implication of endothelial progenitor cells. Foresta C; De Toni L; Ferlin A; Di Mambro A Expert Rev Mol Diagn; 2010 Jan; 10(1):89-105. PubMed ID: 20030028 [TBL] [Abstract][Full Text] [Related]
49. The promise of EPC-based therapies on vascular dysfunction in diabetes. Georgescu A; Alexandru N; Constantinescu A; Titorencu I; Popov D Eur J Pharmacol; 2011 Nov; 669(1-3):1-6. PubMed ID: 21839073 [TBL] [Abstract][Full Text] [Related]
50. Endothelial progenitor cells: a new target for the prevention of cardiovascular diseases. Brixius K; Funcke F; Graf C; Bloch W Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):705-10. PubMed ID: 17001208 [TBL] [Abstract][Full Text] [Related]
51. Transplantation of endothelial progenitor cells overexpressing endothelial nitric oxide synthase enhances inhibition of neointimal hyperplasia and restores endothelium-dependent vasodilatation. Cui B; Huang L; Fang Y; Guo R; Yin Y; Zhao X Microvasc Res; 2011 Jan; 81(1):143-50. PubMed ID: 20888843 [TBL] [Abstract][Full Text] [Related]
52. Endothelial progenitor cells: the promise of cell-based therapies for acute lung injury. Mao M; Xu X; Zhang Y; Zhang B; Fu ZH Inflamm Res; 2013 Jan; 62(1):3-8. PubMed ID: 23138575 [TBL] [Abstract][Full Text] [Related]
53. Proangiogenic hematopoietic cells of monocytic origin: roles in vascular regeneration and pathogenic processes of systemic sclerosis. Yamaguchi Y; Kuwana M Histol Histopathol; 2013 Feb; 28(2):175-83. PubMed ID: 23275301 [TBL] [Abstract][Full Text] [Related]
54. Challenges in vascular repair by endothelial progenitor cells in diabetic patients. António N; Fernandes R; Ribeiro CF; Providência LA Cardiovasc Hematol Disord Drug Targets; 2010 Sep; 10(3):161-6. PubMed ID: 20678063 [TBL] [Abstract][Full Text] [Related]
55. Endothelial progenitor cell culture for vascular regeneration. Ishikawa M; Asahara T Stem Cells Dev; 2004 Aug; 13(4):344-9. PubMed ID: 15345127 [TBL] [Abstract][Full Text] [Related]
56. Endothelial progenitor cells: a promising therapeutic alternative for cardiovascular disease. Dong C; Goldschmidt-Clermont PJ J Interv Cardiol; 2007 Apr; 20(2):93-9. PubMed ID: 17391216 [TBL] [Abstract][Full Text] [Related]
57. In vivo perfusion of human skin substitutes with microvessels formed by adult circulating endothelial progenitor cells. Kung EF; Wang F; Schechner JS Dermatol Surg; 2008 Feb; 34(2):137-46. PubMed ID: 18190540 [TBL] [Abstract][Full Text] [Related]
58. Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia. Finney MR; Greco NJ; Haynesworth SE; Martin JM; Hedrick DP; Swan JZ; Winter DG; Kadereit S; Joseph ME; Fu P; Pompili VJ; Laughlin MJ Biol Blood Marrow Transplant; 2006 May; 12(5):585-93. PubMed ID: 16635794 [TBL] [Abstract][Full Text] [Related]
59. Human umbilical cord-derived endothelial progenitor cells promote growth cytokines-mediated neorevascularization in rat myocardial infarction. Hu CH; Li ZM; DU ZM; Zhang AX; Yang DY; Wu GF Chin Med J (Engl); 2009 Mar; 122(5):548-55. PubMed ID: 19323906 [TBL] [Abstract][Full Text] [Related]
60. Endothelial progenitor cells in pulmonary hypertension - dawn of cell-based therapy? Toshner M; Morrell NW Int J Clin Pract Suppl; 2010 Jan; (165):7-12. PubMed ID: 19958395 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]